TLC D-99: Partner Pfizer Inc. began two Phase III trials

The Liposome Co. Inc. (LIPO) Product: TLC D-99 liposomal doxorubicin Indication: Metastatic breast cancer Status: Partner Pfizer Inc. began two Phase III trials, one against conventional doxorubicin...